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Numerous studies have reported an association between nasal obstruction and obstructive sleep apnea syndrome (OSAS), but the
precise nature of this relationship remains to be clarified. This paper aimed to summarize data and theories on the role of the
nose in the pathophysiology of sleep apnea as well as to discuss the benefits of surgical and medical nasal treatments. A number
of pathophysiological mechanisms can potentially explain the role of nasal pathology in OSAS. These include the Starling resistor
model, the unstable oral airway, the nasal ventilatory reflex, and the role of nitric oxide (NO). Pharmacological treatment presents
some beneficial effects on the frequency of respiratory events and sleep architecture. Nonetheless, objective data assessing snoring
and daytime sleepiness are still necessary. Nasal surgery can improve the quality of life and snoring in a select group of patients with
mild OSAS and septal deviation but is not an effective treatment for OSA as such. Despite the conflicting results in the literature,
it is important that patients who are not perfectly adapted to CPAP are evaluated in detail, in order to identify whether there are
obstructive factors that could be surgically corrected.
1. Introduction
In “Morbis Popularibis,” Hippocrates observed that nasal
polyps were associated with restless sleep [1]. In practice,
most people experience difficulty sleeping during episodes
of nasal congestion associated with upper airways infections.
Thus, a link between nasal breathing and sleep, as well as
an improvement in sleep quality after a relief of the nasal
obstruction, appears to be intuitive [2].
Many nose and pharynx abnormalities may cause or
worsen snoring and sleep apnea, such as septal deviation,
nasal polyps, turbinate hypertrophy, and rhinitis. Adenoid
hypertrophy, nasopharyngitis, and nasopharyngeal tumors
can also cause narrowing of the airways in the nasopharyn-
geal region [3].
Epidemiological studies have demonstrated a relation-
ship between the measure of nasal airflow and snoring
[4], but attempts to find a linear correlation between nasal
obstruction and sleep apnea have been less successful [5].
A weak correlation between nasal resistance measured by
posterior rhinomanometry and severity of sleep apnea has
been recently reported [6].
This paper aimed to summarize data and theories on the
role of the nose in the pathophysiology of sleep apnea as
well as to discuss the benefits of surgical and medical nasal
treatments.
2. Nasal Involvement in the
Pathophysiology of Obstructive Sleep
Apnea Syndrome (OSAS)
The nose accounts for over 50% of the total upper airway
resistance and plays an important role in the establishment of
physiological functions such as humidification, heating, and
air filtration [7].
Among the places of greatest resistance to nasal airflow
are the vestibule and nasal valve area, determined by the alar
cartilages, septum, and inferior turbinates [8].
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The nasal mucosa is a dynamic organ controlled by
the autonomic nervous system. Periodic nasal congestion
and decongestion have been termed the “nasal cycle” by
Heetderks [9]. This cycle occurs in approximately 80% of the
adult population. In patients with permanent unilateral nasal
obstruction, the nasal cycle may contribute to a significant
increase in total airway resistance [10].
In healthy individuals, the lateral decubitus increases
congestion in the ipsilateral nasal cavity and reduces airflow
resistance in the contralateral nasal cavity.This does not occur
due to a hydrostatic effect, but rather as a reflex response
caused by asymmetric pressure on the body [11, 12].This reflex
interrupts the nasal cycle [13]. However, in the assessment of
both nasal cavities, no significant changes were observed in
the cross-sectional area when comparing supine and lateral
decubitus [14].
To fully explain the relationship between airflow, nasal
obstruction, and sleep apnea, it is necessary to understand
some dynamic theories of physics.
Among the physiological mechanisms that elucidate the
relationship between nasal airflow and breathing during sleep
are the Starling resistor model, the unstable oral airway
proposition, the nasal respiratory reflex, and the role of nitric
oxide (NO) [2].
According to the Starling resistor model (Figure 1), the
upper airways function as a hollow tube with a constriction
near the entrance hole, which corresponds to the nostrils,
and a posterior collapsible segment, which corresponds to
the oropharynx. This model predicts that the presence of
a further upstream obstructive factor (nose) will generate
a suction force, that is, a negative intraluminal pressure
downstream (oropharynx), resulting in pharyngeal collapse
in predisposed individuals [15, 16].
A closed jaw and proper dental occlusion stabilize the
flow in the upper airways [17]. When nasal resistance
exceeds a certain level, an air bypass occurs and leads to
mouth breathing, resulting in a decrease in the retroglossal
dimension, due to the subsequent retraction of the tongue,
narrowing of the pharyngeal lumen, and increased oscillation
and vibration of the soft palate and redundant tissue of
the pharynx [14]. This shift from nasal to oral breathing is
physiologically disadvantageous to the individual, leading to
an unstable breathing pattern [2].
Central respiratory events have also been increasingly
associated with oral breathing during sleep. Tanaka and
Honda [18] proposed that, after a switch to oral breathing
during sleep, there is greater CO
2
elimination during expi-
ration, caused by an increase in respiratory stimulus. The
increase in central apneas suggests that the nose plays an
important role in the regulation of respiration and not only
in the maintenance of airway patency.
A third factor is the nasal ventilatory reflex. An experi-
mental application of local anesthetics in the nasal mucosa
of healthy patients led to a significant increase of obstructive
and central apnea episodes, of the same magnitude as those
reported with complete nasal obstruction [19]. Similar results
from other experiments [20] confirmed that the activation of
nasal receptors during nasal breathing had a direct positive
effect on spontaneous ventilation, leading to a higher resting
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Figure 1: Starling resistor model.
breathing frequency and minute ventilation. Mouth breath-
ing reduces the activation of these nasal receptors, leading
to deactivation of the nasal-respiratory reflex and reduction
of spontaneous ventilation, which can trigger respiratory
events in susceptible individuals with subclinical OSAS [21]
or exacerbate apnea episodes [22].
Finally, NO appears to play a role in maintaining the
patency of the upper airways, as a transmitter between the
nose, pharyngeal muscles, and lungs [23]. NO is produced
in significant quantities in the nose and in the paranasal
sinuses and has been proven (including in clinical practice)
to be a potent pulmonary vasodilator, improving oxygenation
and ventilation-perfusion ratio [24]. As the total amount of
inspiredNO varies according to the nasal flow [25], it appears
logical that a decrease in nasal breathing would result in
reduction of NO delivery to the lungs and a reduction in
blood oxygenation. NO also plays a role in the maintenance
of muscle tone, regulation of neuromuscular pathways in
the pharyngeal muscles, spontaneous respiration, and sleep
regulation. In general, the role ofNO in the regulation of nasal
OSAS, although probably significant, is still not completely
understood [26].
The nasal pathophysiology in the pathogenesis of OSAS
is summarized in Table 1.
3. Clinical and Experimental Evidence
Evidence suggests that experimental reduction of nasal
patency and flow has a significant effect on breathing during
sleep.
Suratt et al. [27] induced obstructive apneas in healthy
subjects through nasal occlusion with gauze. Lavie et al. [28]
investigated the influence of partial and complete obstruction
of the nose in healthy subjects and observed a significant
increase in the number of apneas during sleep.
Evidence from several observational and cross-sectional
studies demonstrates that the objective increase in measures
of nasal resistance and the presence of allergic rhinitis
(AR) are associated with OSAS. Lofaso et al. [6] performed
posterior rhinomanometry in 528 patients and observed an
increased nasal resistance in OSAS patients compared to the
control group. In a large population study, Young et al. [29]
identified chronic nasal congestion as a risk factor for OSAS.
Data from an electromyographic study in healthy men
performed by Basner et al. [30] demonstrated that the upper
airway tone is lower during oral breathing than during nasal
breathing, suggesting that the activity of the dilator muscles
of the upper airway can be modulated by receptors in the
International Journal of Otolaryngology 3
Table 1: Nasal pathophysiology in the pathogenesis of OSAS.
Starling resistor model Increased nasal resistance results in negative oropharyngeal pressure (suction force).
Instability of mouth breathing Significant increase in nasal resistance generates higher fraction of oral breathing, leadingto unstable airway.
Nasal ventilatory reflex Decrease in nasal airflow results in less activation of nasal receptors and, consequently,inhibition of muscle tone, respiratory rate, and minute ventilation.
Nitric oxide (NO) Decrease in nasal flow generates lower concentration of pulmonary NO with reducedventilation-perfusion ratio.
nasal mucosa, sensitive to airflow or pressure. However, two
other studies demonstrated that the airway did not affect
the electromyographic activity of the genioglossus muscle
in normal individuals, but other pharyngeal dilator muscles
have not been studied [31, 32].
Epidemiological studies [33] demonstrated that AR
affects 9% to 42% of the population.Themechanism through
which allergic rhinitis causes poor quality of sleep and
daytime fatigue is not entirely clear, but it is believed that
several factors are involved. Inflammatory mediators such
as interferon- (IFN-) gamma, tumor necrosis factor- (TNF-)
alpha, interleukin- (IL-) 1b, IL-4, IL-10 [34], postural changes,
and certain therapeutic agents, such as antihistamines, may
have a direct impact on sleep regulation. One study described
a direct association between nasal resistance and the severity
of OSAS in patients with AR [35], as well as between
nasal obstruction and subjective sleep quality and daytime
sleepiness [36]. A recent study observed that both the AR and
nonallergic rhinitis (NAR) are associated with impaired sleep
quality and demonstrated complaints in up to 83% of patients
with NAR [37].
In a recent review, McNicholas [38] attempted to syn-
thesize these apparently conflicting results, indicating that
reversible nasal obstruction is perhaps more closely associ-
ated with OSAS than with permanent nasal obstruction.This
finding was observed in studies of patients with temporary
obstruction (including AR and iatrogenic causes), which
demonstrated a more consistent association with OSAS than
studies of patients with structural abnormalities, such as a
deviated nasal septum.
Thus, it appears that nasal obstruction, especially the
reversible type (whether artificial or disease-induced), is
associatedwith snoring andmildOSAS. Nonetheless, a direct
correlation between the degree of nasal obstruction and the
severity of OSAS has not been observed; nasal obstruction
does not appear to be the main contributing factor in the
majority of patients with moderate to severe OSAS.
These are some lines of evidence that, even with limited
methodology, show how the nasal respiratory dysfunction
influences sleep apnea.
4. Nasal Treatment in OSAS
Treatment options for cases with nasal obstruction include
nasal dilators, medical treatment, and surgical intervention.
Some clinical trials have been performed, aiming to analyze
the therapeutic possibilities; however, the evaluation of the
results was not uniformly objective. Many of the studies are
not randomized, do not include a control group, and have a
small sample size and relatively short follow-up period [39].
5. Conservative Treatment
In patients with nasal obstruction secondary to chronic
rhinitis, themain cause of increased nasal resistance is edema
and turbinate hypertrophy. Among the options for drug
treatment are topical corticosteroids and sympathomimetic
decongestants.Thesemedications reduce the levels of inflam-
matory mediators, or even directly cause vasoconstriction,
thereby leading to a decrease in nasal resistance and improved
sleep [39].
There is only one randomized controlled trial assessing
the effect of topical nasal corticosteroids in adult OSAS
(Table 1) [40]. In that study, Kiely et al. evaluated the effect
of topical nasal fluticasone for four weeks in 23 patients with
chronic rhinitis: 13 had moderate to severe OSAS (mean
apnea-hypopnea index [AHI]: 26.5) and ten patients were
snorers without OSAS (mean AHI: 3). A reduction in AHI
(mean: −6.5) and in nasal resistance was observed in the
OSAS group after treatment with fluticasone when compared
to placebo. However, there was no improvement in subjective
sleep quality (reported by the patient, or improvement in
the snoring intensity reported by the partner), in sleep
architecture (no change in the duration of REM sleep), or
in oxyhemoglobin desaturation index (desaturation between
average and minimum levels) in either group.
These findings suggest that nasal obstruction due to
allergic rhinitis favors worsening of sleep apnea and that
treatment with topical corticosteroids can be somewhat
beneficial in cases of mild to moderate OSAS.
Studies on nasal decongestants, such as oxymetazoline
[28, 41], were limited and were inconclusive (Table 2). The
results demonstrate that nasal decongestants, whether or
not associated with nasal dilators, are not effective in the
management of OSA, as no improvement was observed in the
degree of daytime sleepiness or AHI [42–45]. As their clinical
use is limited to only a few days, nasal decongestants cannot
be used for OSAS management.
It can be concluded that pharmacological improvement
in nasal patency in patients with OSAS and chronic nasal
obstruction presents some beneficial effects on the frequency
of respiratory events and sleep architecture. Nonetheless,
objective data assessing snoring and daytime sleepiness are
still necessary.
The use of nasal dilators is an option for increasing
nasal patency in the narrowest part of the airway, the nasal
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Table 2: Studies on topical medication for the treatment of sleep disorders.
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valve. Two of the nasal dilators available in the market are
an external device, Breathe Right (CNS Inc.; Bloomington,
MN, USA), and an internal device, Nozovent (Prevancure
AB; Fro¨lunda, Sweden). Five studies with small sample were
retrieved, three using Breathe Right and two using Nozovent
(Table 3) [46–48, 50].
Nasal dilators are generally not recommended in patients
with OSAS, but they may be beneficial for those with simple
snoring associated with rhinitis and/or nasal valve stenosis.
Since they are affordable devices with few side effects,
they can be useful in some selected cases, especially as a
conservative option for patients with indication for surgical
correction of the nasal valve.
6. Surgical Treatment
Nasal obstruction in patients with OSAS may be caused by
septal deviation, nasal polyps, and turbinate hypertrophy,
among several other abnormalities. In this context, surgical
interventions, such as septoplasty, rhinoseptoplasty, func-
tional endoscopic sinus surgery, turbinectomy, and nasal
valve surgery, appear to be a good therapeutic option [51].
There is also a group of patients who may benefit
from surgical intervention not for curative purposes, but as
an adjuvant treatment to improve the effectiveness of the
main therapeutic option, continuous positive airway pressure
(CPAP).
Li et al. [52, 53] recently addressed the role of nasal
surgery in patients with snoring andOSAS from two different
perspectives. Initially [52], the efficacy of nasal surgery for
relief of snoring and OSAS in patients with septal deviation
was assessed. The authors concluded that complete relief of
snoring was achieved in only 12% of patients. Secondly, the
improvement in quality of life after nasal surgery alone in
patients with OSAS and nasal obstruction was assessed [53].
This parameter was evaluated through generic and disease-
specific questionnaires. Li et al. concluded that it is possible
to significantly improve the quality of life by correcting an
obstructed nasal airway and thus substantiated the role of
nasal surgery in treating these patients. Notwithstanding,
despite the significant improvement observed in the qual-
ity of life parameters, there was no statistically significant
improvement in the objective polysomnographic data. This
discrepancy between objective and subjective outcomes was
also observed in several other similar studies after nasal
surgery alone for OSAS treatment. Verse et al. [54] studied
a cohort of 26 patients, 19 of whom had OSAS and seven
of whom were simple snorers. A variety of nasal surgical
procedures, including rhinoplasty, septoplasty, endoscopic
sinus surgery, and nasal valve surgery, were performed.
They concluded that although nasal surgery significantly
improved subjective sleep quality and daytime sleepiness,
the surgical response rate in the apnea group was only 15%,
based on objective parameters (AHI). Four patients presented
worsening of sleep apnea, despite the reduction in arousal
index. This paradoxical effect can be explained by the “first
night effect,” which occurs when the patient has the initial,
preoperative, sleep study for the first time, he does not sleep
well and as a result the study it may not reflect the true
severity of the sleep apnea. In the postoperative evaluation,
when the patient has already adapted to the methodology of
the examination, the severity of the problem becomes more
evident.
Morinaga et al. [55] evaluated how the pharyngeal mor-
phology affects the outcomes of nasal surgery in patients
with OSAS and nasal obstruction. The morphological char-
acteristics analyzed included degree of tonsillar hypertrophy,
Mallampati grade, and retroglossal space. They concluded
that the most favorable surgical outcomes were observed in
subjects whose soft palate was positioned higher and/or had
larger retroglossal dimensions. Conversely, Li et al. [52] found
a relationship between the degree of tonsillar hypertrophy
and surgical outcomes. The most important (and only)
randomized study was conducted in 2007, by Koutsourelakis
et al., in Athens [56], who divided 49 patients with septal
deviation and OSAS into two groups; one group underwent
septoplasty and the other, a sham surgery. Despite the sub-
jective improvement in nasal patency, no objective changes
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were observed on AHI or daytime sleepiness, assessed by the
Epworth sleepiness scale. However, in the septoplasty group,
four patients (14.8%) responded to surgery, according to the
Sher criteria (AHI reduction by 50% or more), and only one
patient was disease-free (AHI < 5). It was concluded that
nasal surgery can improve the quality of life and snoring
in a select group of patients with mild OSAS and septal
deviation. Nasal surgery is certainly not the most effective
treatment for all patients with OSAS, but further studies can
better define subgroups of patients who can benefit from the
surgical procedure.
7. Nasal Obstruction and CPAP
CPAP is the treatment of choice for moderate or severe
OSAS; however, the rate of adherence to this form of therapy
is less than 70% [57]. Over 50% of CPAP users complain
of significant nasal symptoms, such as nasal congestion,
rhinorrhea, nasal dryness, and sneezing [58], which may
becomemore significant if the patient presents any structural
abnormality of the nose.
Since the CPAP mask is in contact with the nose, it
is reasonable to assume that nasal alterations constitute a
limitation to its use.The presence of functional or anatomical
abnormalities in the nasal cavity may require greater CPAP
pressure titration for the elimination of respiratory events,
causing patient discomfort and hindering adaptation to the
device. Nonetheless, attributing the low adherence to CPAP
to a condition of increased nasal resistance is a controversial
hypothesis.
Ta´rrega et al. [59] evaluated, through rhinomanometry,
125 patients with indication for CPAP therapy and observed
no correlation between nasal resistance andCPAP adherence.
Haddad et al. [60] investigated the contribution of nasal
factors on CPAP adherence and observed that the highest
values of body mass index (BMI), neck circumference, and
AHI were found in the group of patients with good CPAP
adherence,while nasal parameters such as rhinoscopy, nasofi-
broscopy, and acoustic rhinometry showed no differences
between the groups with good or poor adherence.
Conversely, Morris et al. [61] observed a greater mini-
mum cross-sectional area in the interior turbinate of patients
with good CPAP adherence. These results were corroborated
by Sugiura et al. [62], who observed that nasal resistance
was lower in patients who used CPAP during titration
polysomnography. These data demonstrate the need of good
nasal patency during the patient’s initial adaptation to the
device. So et al. [63] also investigated 36 patients using
acoustic rhinometry and observed that the sum of the nasal
area was greater in the group of patients with good CPAP
adherence, but only in those with AHI < 60/hour.
Despite the conflicting results in the literature, it is
important that patients who are not perfectly adapted to
CPAP are evaluated in detail, in order to identify whether
there are obstructive factors that could be surgically cor-
rected. In a group of patients who underwent radiofrequency
turbinectomy, Powell et al. [64] demonstrated a subjective
improvement of nasal obstruction, which, in turn, increased
CPAP adherence. Similarly, Friedman et al. [65] showed
a significant decrease in the levels of CPAP titration after
nasal surgery alone. In that study, a reduction in pressure
required for the cessation of obstructive events was observed
in patients with mild, moderate, and severe OSAS. The
average reduction in CPAP titration pressure was 9.3 cmH
2
O
preoperatively to 6.7 cmH
2
O postoperatively. Nakata et al.
[66] assessed 12 patients with nasal obstruction and severe
OSAS who did not respond to treatment with CPAP. After
nasal surgery, a significant decrease in nasal resistance and
a significant increase in minimum O
2
saturation during
sleep were observed. However, no change was evidenced in
AHI, despite the decrease in CPAP titration pressure from
16.8 cmH
2
O to 12 cmH
2
O in five patients.
8. Final Considerations
Despite the recent progress in the study of the relation
between OSAS and nasal obstruction, there are still areas
of doubt. Many of the studies investigating this relationship
had an inappropriate sample size, poorly defined patient
populations, inadequate control groups, and inappropriate
techniques to objectively evaluate nasal resistance.
It is established that an improvement in nasal resis-
tance, whether through surgery, medication, or use of nasal
dilators, may improve self-reported sleep quality. However,
these results are not always followed by improvement in
polysomnographic parameters. Despite the lack of evidence
demonstrating the success of nasal surgery as an isolated
treatment formoderate and severeOSAS, surgical procedures
that improve nasal patency have a role in relieving symptoms
of simple snoring and as part of multiple-level surgery in
patients with OSAS. Nasal surgery may help in OSA patients
who do not tolerate CPAP therapy, when there is a local
obstructive factor in the nose.
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